Caribou Biosciences (CRBU) Non-Current Deferred Tax Liability (2020 - 2025)
Caribou Biosciences' Non-Current Deferred Tax Liability came in at $548,000 for Q3 2025, down 1.6% from $557,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Caribou Biosciences (CRBU) Non-Current Deferred Tax Liability (2020 - 2025) Analysis & Trends
Going back to Q4 2020, Caribou Biosciences' Non-Current Deferred Tax Liability data covers 19 quarters.
- Non-Current Deferred Tax Liability carries a four-year compound annual growth rate of 37.1% (FY2020 to FY2024).
- Going back by year, Non-Current Deferred Tax Liability was $557,000 in FY2023 (+46.2%), $381,000 in FY2022 (-20.0%), $476,000 in FY2021 (+207.1%) and $155,000 in FY2020.
- The five-year range for quarterly Non-Current Deferred Tax Liability is $155,000 (Q4 2020) to $557,000 (Q3 2024).
- Year-over-year, Non-Current Deferred Tax Liability has declined for four consecutive quarters, with growth averaging 22.3% over the last eight quarters.
- The fastest year-over-year change in Non-Current Deferred Tax Liability over five years came in Q4 2021 (growth of 207.1%), and the weakest in Q2 2023 (a decline of 20.0%).
- Business Quant data shows CRBU's Non-Current Deferred Tax Liability at $548,000 (Q2 2025), $548,000 (Q1 2025) and $548,000 (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Caribou Biosciences | 134.61 Mn | -381.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 548,000.00 |
| Jun 30, 2025 | 548,000.00 |
| Mar 31, 2025 | 548,000.00 |
| Dec 31, 2024 | 548,000.00 |
| Sep 30, 2024 | 557,000.00 |
| Jun 30, 2024 | 557,000.00 |
| Mar 31, 2024 | 556,000.00 |
| Dec 31, 2023 | 557,000.00 |
| Sep 30, 2023 | 381,000.00 |
| Jun 30, 2023 | 380,000.00 |
| Mar 31, 2023 | 382,000.00 |
| Dec 31, 2022 | 381,000.00 |
| Sep 30, 2022 | 475,000.00 |
| Jun 30, 2022 | 475,000.00 |
| Mar 31, 2022 | 476,000.00 |
| Dec 31, 2021 | 476,000.00 |
| Sep 30, 2021 | 155,000.00 |
| Jun 30, 2021 | 155,000.00 |
| Dec 31, 2020 | 155,000.00 |
API Access
Caribou Biosciences Non-Current Deferred Tax Liability API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deferred-tax-liability", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();